|
1
|
A structural approach to selection bias.
|
Epidemiology
|
2004
|
16.44
|
|
2
|
Transmissibility of 1918 pandemic influenza.
|
Nature
|
2004
|
16.14
|
|
3
|
Transmission dynamics and control of severe acute respiratory syndrome.
|
Science
|
2003
|
14.70
|
|
4
|
Doubly robust estimation in missing data and causal inference models.
|
Biometrics
|
2005
|
9.67
|
|
5
|
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.
|
Lancet
|
2002
|
9.66
|
|
6
|
Instruments for causal inference: an epidemiologist's dream?
|
Epidemiology
|
2006
|
8.50
|
|
7
|
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
|
Epidemiology
|
2008
|
6.87
|
|
8
|
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.
|
Lancet
|
2005
|
6.60
|
|
9
|
On the efficacy of screening for breast cancer.
|
Int J Epidemiol
|
2004
|
6.30
|
|
10
|
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.
|
Am J Epidemiol
|
2005
|
6.20
|
|
11
|
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
|
AIDS
|
2010
|
5.85
|
|
12
|
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.
|
Am J Epidemiol
|
2003
|
5.81
|
|
13
|
Estimating causal effects from epidemiological data.
|
J Epidemiol Community Health
|
2006
|
5.61
|
|
14
|
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
|
Ann Intern Med
|
2011
|
5.35
|
|
15
|
Comparison of dynamic treatment regimes via inverse probability weighting.
|
Basic Clin Pharmacol Toxicol
|
2006
|
5.25
|
|
16
|
When is baseline adjustment useful in analyses of change? An example with education and cognitive change.
|
Am J Epidemiol
|
2005
|
4.54
|
|
17
|
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
|
Stat Med
|
2002
|
4.15
|
|
18
|
Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.
|
Int J Biostat
|
2010
|
3.97
|
|
19
|
Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions.
|
Am J Epidemiol
|
2012
|
3.77
|
|
20
|
Structural accelerated failure time models for survival analysis in studies with time-varying treatments.
|
Pharmacoepidemiol Drug Saf
|
2005
|
3.05
|
|
21
|
Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.
|
Stat Med
|
2004
|
2.87
|
|
22
|
The identification of synergism in the sufficient-component-cause framework.
|
Epidemiology
|
2007
|
2.77
|
|
23
|
Causal directed acyclic graphs and the direction of unmeasured confounding bias.
|
Epidemiology
|
2008
|
2.60
|
|
24
|
Directed acyclic graphs, sufficient causes, and the properties of conditioning on a common effect.
|
Am J Epidemiol
|
2007
|
2.58
|
|
25
|
When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.
|
Int J Biostat
|
2010
|
2.50
|
|
26
|
Intervening on risk factors for coronary heart disease: an application of the parametric g-formula.
|
Int J Epidemiol
|
2009
|
2.48
|
|
27
|
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.
|
Am J Epidemiol
|
2005
|
2.20
|
|
28
|
A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.
|
Am J Epidemiol
|
2017
|
2.05
|
|
29
|
Generation interval contraction and epidemic data analysis.
|
Math Biosci
|
2008
|
2.04
|
|
30
|
Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model.
|
Am J Epidemiol
|
2007
|
2.00
|
|
31
|
Multiply robust inference for statistical interactions.
|
J Am Stat Assoc
|
2008
|
1.98
|
|
32
|
Second look at the spread of epidemics on networks.
|
Phys Rev E Stat Nonlin Soft Matter Phys
|
2007
|
1.90
|
|
33
|
Four types of effect modification: a classification based on directed acyclic graphs.
|
Epidemiology
|
2007
|
1.83
|
|
34
|
Incorporating prior beliefs about selection bias into the analysis of randomized trials with missing outcomes.
|
Biostatistics
|
2003
|
1.76
|
|
35
|
Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula.
|
Stat Biosci
|
2011
|
1.73
|
|
36
|
Identifiability, exchangeability and confounding revisited.
|
Epidemiol Perspect Innov
|
2009
|
1.65
|
|
37
|
Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.
|
Epidemiology
|
2010
|
1.64
|
|
38
|
Network-based analysis of stochastic SIR epidemic models with random and proportionate mixing.
|
J Theor Biol
|
2007
|
1.62
|
|
39
|
Randomized trials analyzed as observational studies.
|
Ann Intern Med
|
2013
|
1.60
|
|
40
|
On doubly robust estimation in a semiparametric odds ratio model.
|
Biometrika
|
2009
|
1.57
|
|
41
|
Marginal structural models for sufficient cause interactions.
|
Am J Epidemiol
|
2010
|
1.52
|
|
42
|
Weight Loss and Coronary Heart Disease: Sensitivity Analysis for Unmeasured Confounding by Undiagnosed Disease.
|
Epidemiology
|
2016
|
1.39
|
|
43
|
Early versus deferred antiretroviral therapy for HIV.
|
N Engl J Med
|
2009
|
1.35
|
|
44
|
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.
|
Am J Epidemiol
|
2016
|
1.29
|
|
45
|
Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part II: proofs of results.
|
Int J Biostat
|
2010
|
1.29
|
|
46
|
Pandemic influenza: risk of multiple introductions and the need to prepare for them.
|
PLoS Med
|
2006
|
1.26
|
|
47
|
Effect decomposition in the presence of an exposure-induced mediator-outcome confounder.
|
Epidemiology
|
2014
|
1.25
|
|
48
|
Improved double-robust estimation in missing data and causal inference models.
|
Biometrika
|
2012
|
1.22
|
|
49
|
Relation between three classes of structural models for the effect of a time-varying exposure on survival.
|
Lifetime Data Anal
|
2009
|
1.14
|
|
50
|
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
|
AIDS
|
2012
|
1.11
|
|
51
|
Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study.
|
PLoS Med
|
2011
|
1.08
|
|
52
|
Selecting on treatment: a pervasive form of bias in instrumental variable analyses.
|
Am J Epidemiol
|
2015
|
1.07
|
|
53
|
On weighting approaches for missing data.
|
Stat Methods Med Res
|
2011
|
1.05
|
|
54
|
A mapping between interactions and interference: implications for vaccine trials.
|
Epidemiology
|
2012
|
0.97
|
|
55
|
Identification, estimation and approximation of risk under interventions that depend on the natural value of treatment using observational data.
|
Epidemiol Method
|
2014
|
0.92
|
|
56
|
Time-dependent cross ratio estimation for bivariate failure times.
|
Biometrika
|
2011
|
0.92
|
|
57
|
Higher Order Inference On A Treatment Effect Under Low Regularity Conditions.
|
Stat Probab Lett
|
2011
|
0.91
|
|
58
|
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
|
Clin Infect Dis
|
2015
|
0.83
|
|
59
|
Definition and evaluation of the monotonicity condition for preference-based instruments.
|
Epidemiology
|
2015
|
0.82
|
|
60
|
Re: Causality and causal inference in epidemiology: the need for a pluralistic approach.
|
Int J Epidemiol
|
2016
|
0.78
|
|
61
|
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.
|
J Acquir Immune Defic Syndr
|
2016
|
0.78
|
|
62
|
Multiple outbreaks and flu containment plans.
|
Science
|
2006
|
0.76
|
|
63
|
The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.
|
Am J Epidemiol
|
2015
|
0.75
|
|
64
|
Introduction.
|
Am J Addict
|
2010
|
0.75
|